Exposure-Response relationships of dapagliflozin on cardio-renal risk markers and adverse events: a pooled analysis of 13 phase II/III trials
| Image |  |
|---|---|
| Description | scientific article published on 20 April 2020 |
| Author/s | |
| Publication date | April 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |